PDK1 and neoplasm: In our study, we focused on in vivo experiments, which were made possible by the persistence of PDK1 silencing in tumor cells, as shown by prolonged in vitro culture of genetically modified tumor cells as well as by analysis of PDK1 levels in tumors obtained >2 months after s.c. injection of tumor cells.